| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transition metal ion binding | LARGE2 CYP4Z2P EPRS1 CYP4Z1 TRIM26 UBR4 ZNF75D ZFHX3 TRIP12 CXXC1 LARGE1 | 2.85e-04 | 1189 | 54 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | UDP-xylosyltransferase activity | 3.89e-04 | 11 | 54 | 2 | GO:0035252 | |
| GeneOntologyMolecularFunction | xylosyltransferase activity | 3.89e-04 | 11 | 54 | 2 | GO:0042285 | |
| Domain | Ribosomal_L10e_CS | 7.90e-06 | 2 | 53 | 2 | IPR018255 | |
| Domain | Ribosomal_L10e | 7.90e-06 | 2 | 53 | 2 | IPR001197 | |
| Domain | RIBOSOMAL_L10E | 7.90e-06 | 2 | 53 | 2 | PS01257 | |
| Domain | Ribosomal_L10e/L16 | 2.37e-05 | 3 | 53 | 2 | IPR016180 | |
| Domain | - | 2.37e-05 | 3 | 53 | 2 | 3.90.1170.10 | |
| Domain | Ribosomal_L16 | 2.37e-05 | 3 | 53 | 2 | PF00252 | |
| Domain | VWA_2 | 7.86e-05 | 5 | 53 | 2 | PF13519 | |
| Domain | INT_SG_DDX_CT_C | 2.19e-04 | 8 | 53 | 2 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 2.19e-04 | 8 | 53 | 2 | IPR029307 | |
| Domain | Glyco_transf_8 | 3.50e-04 | 10 | 53 | 2 | PF01501 | |
| Domain | Glyco_trans_8 | 3.50e-04 | 10 | 53 | 2 | IPR002495 | |
| Domain | - | 1.57e-03 | 81 | 53 | 3 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 2.00e-03 | 88 | 53 | 3 | IPR029044 | |
| Domain | FERM_M | 7.55e-03 | 46 | 53 | 2 | PF00373 | |
| Domain | FERM_central | 8.53e-03 | 49 | 53 | 2 | IPR019748 | |
| Domain | FERM_domain | 8.53e-03 | 49 | 53 | 2 | IPR000299 | |
| Domain | FERM_1 | 8.87e-03 | 50 | 53 | 2 | PS00660 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE | 1.05e-04 | 6 | 38 | 2 | M47618 | |
| Pubmed | RPL10L PLEK2 EPRS1 LSG1 N4BP2 UBR4 U2AF2 METTL25 SRCAP TRIP12 CXXC1 RPL10 ZNF292 | 3.63e-07 | 1442 | 56 | 13 | 35575683 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 5.81e-07 | 807 | 56 | 10 | 30575818 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | INTS6 RBM27 LSG1 RPS8 U2AF2 HIC2 SRCAP TRIP12 CXXC1 RPL10 ZNF292 | 1.04e-06 | 1082 | 56 | 11 | 38697112 |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15958417 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15661757 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19035517 | ||
| Pubmed | LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE. | 2.55e-06 | 2 | 56 | 2 | 15752776 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25701119 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12417403 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 28236635 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23125099 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 15059886 | ||
| Pubmed | LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE. | 2.55e-06 | 2 | 56 | 2 | 23135544 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 INTS6 RBM27 RPS8 U2AF2 CPT1A SRCAP UBN2 TRIP12 CXXC1 RPL10 | 5.79e-06 | 1294 | 56 | 11 | 30804502 |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 30832689 | ||
| Pubmed | IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10. | 7.63e-06 | 3 | 56 | 2 | 27616053 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 25138275 | ||
| Pubmed | 1.00e-05 | 26 | 56 | 3 | 30352954 | ||
| Pubmed | 1.47e-05 | 1429 | 56 | 11 | 35140242 | ||
| Pubmed | TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | 1.52e-05 | 4 | 56 | 2 | 37324936 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 8661144 | ||
| Pubmed | 1.80e-05 | 340 | 56 | 6 | 24332808 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 19587235 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.88e-05 | 1257 | 56 | 10 | 36526897 | |
| Pubmed | 3.30e-05 | 777 | 56 | 8 | 35844135 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 27793593 | ||
| Pubmed | 4.95e-05 | 601 | 56 | 7 | 33658012 | ||
| Pubmed | 6.05e-05 | 847 | 56 | 8 | 35850772 | ||
| Pubmed | 9.78e-05 | 55 | 56 | 3 | 31640799 | ||
| Pubmed | 1.05e-04 | 151 | 56 | 4 | 18457437 | ||
| Pubmed | 1.11e-04 | 153 | 56 | 4 | 10718198 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.15e-04 | 475 | 56 | 6 | 31040226 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | INTS6 WWOX TRIM26 ZDHHC14 CILK1 U2AF2 ZFHX3 TTC17 CPT1A UBN2 | 1.18e-04 | 1489 | 56 | 10 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 1.23e-04 | 1496 | 56 | 10 | 32877691 | |
| Pubmed | 1.25e-04 | 483 | 56 | 6 | 36912080 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.57e-04 | 724 | 56 | 7 | 36232890 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.61e-04 | 318 | 56 | 5 | 16919269 | |
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 1.66e-04 | 170 | 56 | 4 | 15582152 | |
| Pubmed | Temperature dependence of the control of energy homeostasis requires CART signaling. | 1.66e-04 | 12 | 56 | 2 | 27080622 | |
| Pubmed | AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan. | 1.66e-04 | 12 | 56 | 2 | 24256719 | |
| Pubmed | 1.74e-04 | 172 | 56 | 4 | 26336360 | ||
| Pubmed | 1.92e-04 | 330 | 56 | 5 | 32529326 | ||
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 18272476 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.97e-04 | 332 | 56 | 5 | 32786267 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 1.97e-04 | 332 | 56 | 5 | 30595499 | |
| Pubmed | 2.18e-04 | 72 | 56 | 3 | 12777385 | ||
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 2.29e-04 | 14 | 56 | 2 | 28263302 | |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 2.29e-04 | 14 | 56 | 2 | 27626314 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.32e-04 | 344 | 56 | 5 | 36282215 | |
| Pubmed | 2.34e-04 | 542 | 56 | 6 | 14651853 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.39e-04 | 1318 | 56 | 9 | 30463901 | |
| Pubmed | 2.64e-04 | 15 | 56 | 2 | 2575583 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.89e-04 | 1353 | 56 | 9 | 29467282 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 2.92e-04 | 565 | 56 | 6 | 33567341 | |
| Pubmed | 3.41e-04 | 17 | 56 | 2 | 37080995 | ||
| Pubmed | 3.45e-04 | 206 | 56 | 4 | 34185411 | ||
| Pubmed | 3.56e-04 | 85 | 56 | 3 | 36517592 | ||
| Pubmed | 3.71e-04 | 591 | 56 | 6 | 15231748 | ||
| Pubmed | 3.81e-04 | 87 | 56 | 3 | 12465718 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 3.83e-04 | 18 | 56 | 2 | 25363768 | |
| Pubmed | 3.97e-04 | 1116 | 56 | 8 | 31753913 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.23e-04 | 1425 | 56 | 9 | 30948266 | |
| Pubmed | Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. | 4.28e-04 | 19 | 56 | 2 | 14671302 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.32e-04 | 394 | 56 | 5 | 27248496 | |
| Pubmed | Dysregulation of sonic hedgehog signaling causes hearing loss in ciliopathy mouse models. | 4.75e-04 | 20 | 56 | 2 | 33382037 | |
| Pubmed | A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. | 4.93e-04 | 95 | 56 | 3 | 37211047 | |
| Pubmed | 5.37e-04 | 1168 | 56 | 8 | 19946888 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 5.59e-04 | 639 | 56 | 6 | 23443559 | |
| Pubmed | 5.65e-04 | 418 | 56 | 5 | 34709266 | ||
| Pubmed | 5.84e-04 | 421 | 56 | 5 | 34650049 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 26508642 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 25505333 | ||
| Pubmed | 6.37e-04 | 655 | 56 | 6 | 35819319 | ||
| Pubmed | 6.52e-04 | 244 | 56 | 4 | 30349055 | ||
| Pubmed | 6.62e-04 | 245 | 56 | 4 | 21182205 | ||
| Pubmed | Mitochondrial antiviral-signalling protein is a client of the BAG6 protein quality control complex. | 6.87e-04 | 24 | 56 | 2 | 35543156 | |
| Pubmed | Cascade diversification directs generation of neuronal diversity in the hypothalamus. | 6.87e-04 | 24 | 56 | 2 | 33887179 | |
| Pubmed | Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection. | 6.87e-04 | 24 | 56 | 2 | 33781803 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.27e-04 | 934 | 56 | 7 | 33916271 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 7.36e-04 | 109 | 56 | 3 | 33554859 | |
| Pubmed | 7.46e-04 | 25 | 56 | 2 | 15303970 | ||
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 7.80e-04 | 256 | 56 | 4 | 35777956 | |
| Pubmed | C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. | 8.71e-04 | 27 | 56 | 2 | 29420262 | |
| Pubmed | 8.71e-04 | 27 | 56 | 2 | 30063881 | ||
| Pubmed | MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. | 8.81e-04 | 116 | 56 | 3 | 36307841 | |
| Pubmed | 9.03e-04 | 464 | 56 | 5 | 32457219 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 9.26e-04 | 704 | 56 | 6 | 29955894 | |
| Pubmed | 9.37e-04 | 28 | 56 | 2 | 32868762 | ||
| Pubmed | 9.37e-04 | 28 | 56 | 2 | 35474067 | ||
| Pubmed | Developmental gene expression profiling along the tonotopic axis of the mouse cochlea. | 9.37e-04 | 28 | 56 | 2 | 22808246 | |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 9.37e-04 | 269 | 56 | 4 | 29511261 | |
| Pubmed | 9.74e-04 | 711 | 56 | 6 | 33022573 | ||
| Pubmed | 1.01e-03 | 29 | 56 | 2 | 25681748 | ||
| Pubmed | 1.01e-03 | 29 | 56 | 2 | 28364022 | ||
| Pubmed | 1.01e-03 | 29 | 56 | 2 | 18077674 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.01e-03 | 989 | 56 | 7 | 36424410 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.02e-03 | 477 | 56 | 5 | 31300519 | |
| Pubmed | 1.06e-03 | 1297 | 56 | 8 | 33545068 | ||
| Pubmed | 1.10e-03 | 281 | 56 | 4 | 26725010 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.13e-03 | 283 | 56 | 4 | 30585729 | |
| Cytoband | 1p33 | 8.47e-04 | 35 | 56 | 2 | 1p33 | |
| Cytoband | 4p14 | 1.22e-03 | 42 | 56 | 2 | 4p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p33 | 2.55e-03 | 61 | 56 | 2 | chr1p33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p14 | 3.07e-03 | 67 | 56 | 2 | chr4p14 | |
| Cytoband | Xq26.3 | 3.07e-03 | 67 | 56 | 2 | Xq26.3 | |
| Cytoband | 11p11.2 | 4.67e-03 | 83 | 56 | 2 | 11p11.2 | |
| GeneFamily | Glycosyltransferase family 8 | 1.70e-04 | 9 | 40 | 2 | 436 | |
| GeneFamily | Integrator complex | 4.92e-04 | 15 | 40 | 2 | 1366 | |
| GeneFamily | Cytochrome P450 family 4 | 2.87e-03 | 36 | 40 | 2 | 1003 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.66e-03 | 718 | 40 | 6 | 28 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.47e-03 | 50 | 40 | 2 | 1293 | |
| GeneFamily | L ribosomal proteins | 5.68e-03 | 51 | 40 | 2 | 729 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-06 | 164 | 56 | 5 | d8ecb3de6e34f5f574449e3d2f26fa0b2b7e84e8 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.99e-06 | 164 | 56 | 5 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-06 | 165 | 56 | 5 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | NS-critical-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.52e-05 | 165 | 56 | 4 | 6b1c29dcef5a945786806ddbddddcec0023bd66e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 6.06e-05 | 169 | 56 | 4 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 175 | 56 | 4 | b30589ff9dc18e745afe61f289e6d576c9c6c6b2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.09e-05 | 176 | 56 | 4 | 6b1cf1e98b4509e87f9eea827fa7090ce1e504f1 | |
| ToppCell | lung|World / shred on tissue and cell subclass | 7.41e-05 | 178 | 56 | 4 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.25e-05 | 183 | 56 | 4 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 8.25e-05 | 183 | 56 | 4 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 8.60e-05 | 185 | 56 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.60e-05 | 185 | 56 | 4 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 8.78e-05 | 186 | 56 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | URO-Lymphocyte-B-B_naive|URO / Disease, Lineage and Cell Type | 8.96e-05 | 187 | 56 | 4 | 9ed6a39aae7126ddbd01aec3376113b6b4517383 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.53e-05 | 190 | 56 | 4 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | B_cell_maturation-Naive_B_cell|World / Lineage and Cell class | 9.92e-05 | 192 | 56 | 4 | 58267a11c938a380c6e26f4e4ce63f3b4be79fdc | |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | 1.01e-04 | 193 | 56 | 4 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 | |
| ToppCell | IIH|World / Condition, Cell_class and T cell subcluster | 1.01e-04 | 193 | 56 | 4 | a9af5ccff108d51939ead130583f5b950d3092ed | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-04 | 193 | 56 | 4 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | ASK454-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.01e-04 | 193 | 56 | 4 | 11e1db416dc9a0b99ddb72d6021fba6e25405b5c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-04 | 193 | 56 | 4 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 193 | 56 | 4 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 194 | 56 | 4 | cb9f67366cfa39bd7dfd3b7a6e4672af93350958 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.07e-04 | 196 | 56 | 4 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_3|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-04 | 197 | 56 | 4 | d77bc37a77546a1f0a508486a38a45e571e4645b | |
| ToppCell | Control-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 1.10e-04 | 197 | 56 | 4 | e0ee15188ff0d9df3c3b5ea523553ce18d223c33 | |
| ToppCell | normal_Lung-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.10e-04 | 197 | 56 | 4 | d051617f7cf96485715c343cff72833c2124512d | |
| ToppCell | COVID-19_Severe-B_naive|COVID-19_Severe / disease group, cell group and cell class | 1.10e-04 | 197 | 56 | 4 | b8f18b39435e2229ba3bc07a25eb875d1ec11f6f | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.12e-04 | 198 | 56 | 4 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 199 | 56 | 4 | 2d57afe29276995c500b74da4771b2572bc80587 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 199 | 56 | 4 | accfdf22a2c9e9b926b8328efdadd24979477edf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| Disease | T-cell acute lymphoblastic leukemia (implicated_via_orthology) | 9.13e-06 | 3 | 52 | 2 | DOID:5603 (implicated_via_orthology) | |
| Disease | autistic disorder (implicated_via_orthology) | 1.82e-05 | 4 | 52 | 2 | DOID:12849 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (18:0_20:4) in blood serum | 2.24e-05 | 31 | 52 | 3 | OBA_2045094 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 4.55e-05 | 6 | 52 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 6.36e-05 | 7 | 52 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | 10-undecenoate 11:1n1 measurement | 6.36e-05 | 7 | 52 | 2 | EFO_0021099 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 8.47e-05 | 8 | 52 | 2 | C0796250 | |
| Disease | response to ketamine | 2.49e-04 | 69 | 52 | 3 | EFO_0009748 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 4.58e-04 | 18 | 52 | 2 | OBA_2045079 | |
| Disease | Neurodevelopmental Disorders | 5.99e-04 | 93 | 52 | 3 | C1535926 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 6.26e-04 | 21 | 52 | 2 | OBA_2045076 | |
| Disease | Weight Gain | 7.84e-04 | 102 | 52 | 3 | C0043094 | |
| Disease | West Syndrome | 8.20e-04 | 24 | 52 | 2 | C0037769 | |
| Disease | fatty acid measurement | 1.01e-03 | 436 | 52 | 5 | EFO_0005110 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 1.37e-03 | 31 | 52 | 2 | OBA_2045198 | |
| Disease | alcohol consumption measurement | 1.39e-03 | 1242 | 52 | 8 | EFO_0007878 | |
| Disease | Diabetes Mellitus | 1.46e-03 | 32 | 52 | 2 | C0011849 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKWKKHRQIVKPGFN | 131 | Q8N1L4 | |
| VKKFRQKKQRQWIGP | 406 | P06127 | |
| LHSWKKKFIRFKNGI | 36 | P50416 | |
| KKDNSVHWERPQKPK | 1176 | P01023 | |
| GPKFKDRRLQISWHK | 1001 | Q9P2N5 | |
| FKVHKLKPNLKWRQA | 401 | Q5JSJ4 | |
| LFKVHKAKPTLKWRQ | 396 | Q9UL03 | |
| KVIHWNSPKKLRVKN | 336 | Q8N3Y3 | |
| HWLEKNFSKRUKKTR | 256 | Q92813 | |
| WNSPKKLRVKNKHVE | 381 | O95461 | |
| PWKKHGNRNKKEKSR | 636 | Q9H089 | |
| QKKFKLTRNGHVIWK | 656 | P46199 | |
| EKSIFRIPWKHAGKQ | 46 | Q15306 | |
| WGLHTGPQKTKRKRK | 61 | Q9UKN7 | |
| RWVKEVVKKHPQFIG | 171 | Q58FF6 | |
| HGAEERNRKLKKHWK | 211 | Q8N6Q8 | |
| RKKSGKWYHRRQAVK | 791 | Q5HYC2 | |
| KAHRLQFWKKALPQK | 531 | O00748 | |
| MEHFRWGKPVGKKRR | 141 | P01189 | |
| AKPKWCSKGIKQRIH | 106 | Q8TAC1 | |
| VLASKKVQRPWRKHA | 521 | P05166 | |
| HDKVKPRKIFQWRQL | 246 | Q9P2Q2 | |
| KQKHKDKWKHPERAD | 351 | Q9P0U4 | |
| KNGSFKRKGIERWHR | 31 | Q96BT1 | |
| VVPHGKEKEAERRWK | 446 | Q7Z7M9 | |
| AKWRKREKAGAQTHP | 381 | Q96QS3 | |
| KRRKFWKAKNLQHIP | 1021 | Q86Z14 | |
| DNWHKRRKTGGKRKP | 6 | P62241 | |
| PKMIFNHGRKKRTWN | 256 | Q92990 | |
| RHSTRKKEWGKKEPV | 331 | Q96JB3 | |
| GRQKIHISKKWGFTK | 161 | Q96L21 | |
| KLETKVKRKNLNPHW | 186 | O43581 | |
| EQLKQKKAPVHVKRW | 136 | P07814 | |
| KKAPVHVKRWFGFLE | 141 | P07814 | |
| GRQKIHISKKWGFTK | 161 | P27635 | |
| NKWSKVRHIKGPKDV | 61 | Q9BSH4 | |
| AQKERKLKRQGWTKP | 701 | Q6ZRS2 | |
| TKRGKKVCTHPRKKW | 66 | Q9Y258 | |
| EHKNGEIKPKSRRRW | 391 | Q9UPZ9 | |
| SKWKKHRQIVKPGFN | 131 | Q86W10 | |
| KQGHKRKNWKVRRFV | 256 | Q9NYT0 | |
| KPGKRVIGPRKKFHW | 591 | Q6ZU65 | |
| RWKIKRIQFGFHKKD | 546 | Q5VZP5 | |
| NKRAKWPAIIRDGKF | 1361 | O60281 | |
| KTQWEHPKTGKRKRV | 41 | Q9NZC7 | |
| PRPKKENGKSVHWKL | 56 | Q9H788 | |
| RKKFWVGKPIARVVK | 266 | Q12899 | |
| EWITFQVKRVKKPKG | 836 | Q96AE7 | |
| KKKIAARRKWEVFPG | 31 | Q8IZN3 | |
| GRPRWVDHKDRKEFK | 376 | E7ETH6 | |
| VQKWHRAFPRKKRKK | 326 | P51815 | |
| RHEKKKKVRKYWDVP | 81 | P26368 | |
| DKKHFKLWRRPITGT | 146 | Q9NQZ5 | |
| RVGKWHQDFPVKKRK | 121 | Q96N20 | |
| REKIKGWIKEQAHKF | 1086 | Q14669 | |
| KNKPARWHKAKKVQL | 3606 | Q5T4S7 | |
| KSGLPQKVIKHWFRN | 2181 | Q15911 | |
| WKFKPKELARRNIHG | 546 | Q86UW6 |